An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors.
about
The Wonders of Phosphodiesterase-5 Inhibitors: A Majestic HistoryA review of the efficacy and safety of mirodenafil in the management of erectile dysfunctionClinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an updateUdenafil for the treatment of erectile dysfunctionThe relationship between epilepsy and sexual dysfunction: a review of the literatureThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesPDE5 inhibitors enhance celecoxib killing in multiple tumor types.Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation.Antinociceptive Effect of Vardenafil on Carrageenan-Induced Hyperalgesia in Rat: involvement of Nitric Oxide/Cyclic Guanosine Monophosphate/Calcium Channels Pathway.Phosphodiesterase type 5 inhibitors: back and forward from cardiac indicationsPreclinical pharmacokinetics of TPN729MA, a novel PDE5 inhibitor, and prediction of its human pharmacokinetics using a PBPK model.Inhibition by tadalafil of contractility of isolated nonpregnant human myometriumErectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives.Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility.The Old Made New: Natural Compounds against Erectile Dysfunction.Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?Erectile dysfunction and its management in patients with diabetes mellitus.Further analysis of acute antinociceptive and anti-inflammatory actions of 4-phenylselenyl-7-chloroquinoline in mice.Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model.Erectile Dysfunction in Systemic Sclerosis.Avanafil for the treatment of erectile dysfunction.Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis.Cyclic dinucleotide detection with riboswitch-G-quadruplex hybrid.Results from an online survey investigating ED patients' insights and treatment expectations.Inhibition by sildenafil of contractility of isolated non-pregnant human myometrium.Intracellular calcium concentration of corpus cavernosum smooth muscle cells is decreased by the overexpression of PnNOS gene in adipose tissue-derived stem cells.Non-pharmacological and non-surgical strategies to promote sexual recovery for men with erectile dysfunction.Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study.[Avanafil for the treatment of erectile dysfunction in practice. Non-interventional study AVANTI].Chemsex intoxication involving sildenafil as an adulterant of GHB.
P2860
Q26741387-48FC4FEC-4D3B-4072-970F-FA91D30C6659Q26749094-144DB6D6-EA38-451F-8074-8D7F01942F5DQ26775925-CFDCE911-213E-4570-B175-159F15E3409FQ26851999-8BED537F-286B-4B75-ABF7-294D9DA370EEQ28068847-EA75D851-6E4E-4173-9148-BB59F748D7B2Q35156618-61E7091F-3B2F-4362-A632-38D174F5EF15Q35430943-3A097B4B-750B-4410-AA39-CE3F9E115B1BQ35851963-931D92DA-1690-4954-B336-FC7CA8623339Q36358401-F3A492ED-791F-4837-AF5B-7C933843BFA9Q36460566-9E017F62-8D2E-4BE4-9E1C-1B1C144AF359Q36751935-E58C499F-494B-4FAB-B8EF-684AFE1C7A9DQ37591600-B91DD413-3F89-4480-BED7-A67463437688Q37686844-38877C71-191D-4240-A879-D95EAA3600A2Q38248275-57499210-99AB-4EF9-B412-D1A5EA3335B5Q38479677-7E82526C-07DE-4720-A5FB-F30CBCB65B48Q38542767-BFEF0020-ABF0-4F36-A5E8-F71CB21E13A9Q38615555-F9FDBA99-FA7F-4037-9B79-C5D92ABB7D6CQ38764230-D2F16521-3D28-4F6F-8ECA-5A82AEEADA56Q38857929-C15A0227-0930-47FB-AAA6-32F2F122C5BEQ38893189-FD4D3108-AB82-4093-AA46-DF872A740244Q38896836-88866199-DABC-4D42-82C7-DDA04DE9B208Q39456281-0654851F-399E-4268-BBA0-C46DA529FFC2Q40135508-7D2ED6F6-EA0C-41C7-9448-54EE152FBC4DQ40679944-2E25D990-8A4B-439E-A7D4-AAC234E1ED73Q42718443-8B1E0A58-8CC1-42D8-BDE7-828C08A94390Q45868580-27D64D13-8E69-49BC-BEE0-864AC129501FQ47153841-F657C638-F6B8-4982-B332-25E512DEF008Q48771187-C0FAD85C-881A-4183-A477-974C3127A768Q52837854-9778B144-A1CE-48F2-ACB7-36B4A9E1C9B8Q54194587-7C9FFDD4-BABD-4FC2-9FA1-9AC6DDCC7951
P2860
An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An update on pharmacological t ...... odiesterase type 5 inhibitors.
@en
type
label
An update on pharmacological t ...... odiesterase type 5 inhibitors.
@en
prefLabel
An update on pharmacological t ...... odiesterase type 5 inhibitors.
@en
P2093
P2860
P1476
An update on pharmacological t ...... odiesterase type 5 inhibitors.
@en
P2093
Davide Francomano
Pietro Gareri
Roberto Bruzziches
P2860
P304
P356
10.1517/14656566.2013.799665
P407
P577
2013-05-16T00:00:00Z